Gateway Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Gateway Advisory's IBB Position: Q2 2024 in Review
Gateway Advisory sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 74,490 shares — an estimated $10.2M sold.
Gateway Advisory first reported a position in IBB in Q4 2013 and held it in 3 quarters. The position peaked at $10.2M in Q1 2024. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.
- Gateway Advisory reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
- Gateway Advisory sold 74,490 iShares Biotechnology ETF shares in Q2 2024, an estimated $10.2M.
- Gateway Advisory first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 3 quarters.
- Gateway Advisory's iShares Biotechnology ETF position peaked at $10.2M in Q1 2024.
- 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.
Based on Gateway Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.